Grants per year
Personal profile
Research Interests
Dr. Lukas, sub-specializing in neuro-oncology, is interested in the care of patients with primary brain tumors and spinal cord tumors as well as central nervous system (CNS) metastases. Dr. Lukas's research centers on clinical trials in neuro-oncology. Additionally, he has a strong interest in medical education in the U.S. and internationally and conducts research in neuroscience medical education.
Training Experience
| 2003 | Internship, Cook County Hospital, Chicago |
| 2006 | Residency, University of Chicago Hospitals |
| 2008 | Fellowship, University of Chicago |
Education/Academic qualification
MD, Rush University
… → 2002
Research interests
- Brain Cancer / Nervous System Cancer
- Medical Education
- Neuro-Oncology
- Spinal Cord Tumors
- Spinal Oncology
Fingerprint Dive into the research topics where Rimas Vincas Lukas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 4 Active
Relationship between Psychological Distress an the Efficacy of Immunotherapy in Patients with Glioblastoma
Lukas, R. V. & Wainwright, D. A.
7/1/19 → 6/30/21
Project: Research project
SPORE for Translational Approaches to Brain Cancer
Ahmed, A. U., Balyasnikova, I. V., Bartom, E. T., Brat, D. J., Chandler, J. P., Cheng, S., Horbinski, C. M., Hu, B., James, C. D., Kumthekar, P. U., Leikin, R. G., Lesniak, M. S., Liu, B. P., Lukas, R. V., Platanias, L. C., Sachdev, S., Scholtens, D. M., Stegh, A. H., Stupp, R. & Wainwright, D. A.
8/17/18 → 7/31/23
Project: Research project
Research Output
Leptomeningeal metastasis from solid tumors
Thakkar, J. P., Kumthekar, P., Dixit, K. S., Stupp, R. & Lukas, R. V., Apr 15 2020, In : Journal of the Neurological Sciences. 411, 116706.Research output: Contribution to journal › Review article
A Report from the 2017 Sino-US Medical Education Symposium in Wuhan, China
Lukas, R., Jiang, I., Lio, J., Cooper, B., Dong, H., Fan, J. & Sherer, R., Jan 1 2019, In : Education for Health: Change in Learning and Practice. 32, 2, p. 99-100 2 p.Research output: Contribution to journal › Letter
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Gadgeel, S. M., Lukas, R. V., Goldschmidt, J., Conkling, P., Park, K., Cortinovis, D., de Marinis, F., Rittmeyer, A., Patel, J. D., von Pawel, J., O'Hear, C., Lai, C., Hu, S., Ballinger, M., Sandler, A., Gandhi, M. & Fehrenbacher, L., Feb 2019, In : Lung Cancer. 128, p. 105-112 8 p.Research output: Contribution to journal › Article
6
Scopus
citations
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma (Nature Medicine, (2019), 25, 3, (462-469), 10.1038/s41591-019-0349-y)
Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., Filip, I., Orenbuch, R., Goetz, M., Yamaguchi, J. T., Cloney, M., Horbinski, C., Lukas, R. V., Raizer, J., Rae, A. I., Yuan, J. & 7 others, , Jun 1 2019, In : Nature Medicine. 25, 6, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
2
Scopus
citations
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)
Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Scholtens, D. M., Savoor, R., Zhang, B., Wu, J. D., Horbinski, C., Lukas, R. V., Binder, D. C. & Wainwright, D. A., Mar 4 2019, In : OncoImmunology. 8, 3, 1548242.Research output: Contribution to journal › Comment/debate